Omeros (OMER) Return on Sales [ROS] (2010 - 2026)
Omeros' Return on Sales [ROS] was 0.26% in Q2 2026, up 231.59 percentage points from -231.33% a year earlier and up 176.35 percentage points from the prior quarter.
Powered by 
Analysis
Omeros (OMER) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Omeros' Return on Sales [ROS] was -189.53% through Jun 30, 2026, up 41.80 percentage points year-over-year; for FY2020, it came in at -212.59%, down 81.97 percentage points from FY2019.
- Return on Sales [ROS] shows a five-year change of +314.75 percentage points (FY2015 to FY2020).
- In earlier years, Return on Sales [ROS] was -130.62% in FY2019 (+245.11 pp), -375.73% in FY2018 (-308.01 pp), -67.72% in FY2017 (+62.70 pp) and -130.42% in FY2016 (+396.92 pp).
- The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] in data going back to Q2 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Omeros | 234.42 Mn | -206.99 Mn | 27.73 Mn | 0.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26% |
| Mar 31, 2026 | -176.09% |
| Dec 31, 2025 | -968.65% |
| Sep 30, 2025 | -150.53% |
| Jun 30, 2024 | -1,363.64% |
| Mar 31, 2024 | -3,617.61% |
| Dec 31, 2023 | -211.41% |
| Dec 31, 2021 | -139.04% |
| Sep 30, 2021 | -132.74% |
| Jun 30, 2021 | -158.24% |
| Mar 31, 2021 | -215.04% |
| Dec 31, 2020 | -318.06% |
| Sep 30, 2020 | -97.37% |
| Jun 30, 2020 | -204.58% |
| Mar 31, 2020 | -100.59% |
| Dec 31, 2019 | -70.93% |
| Sep 30, 2019 | -37.18% |
| Jun 30, 2019 | -34.90% |
| Mar 31, 2019 | -88.34% |
| Dec 31, 2018 | -83.91% |
API Access
Omeros Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OMER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "OMER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OMER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();